Allena Pharmaceuticals to Participate Nearly in Upcoming Trader Conferences in November

NEWTON, Mass., Nov. 03, 2020 (Globe NEWSWIRE) — Allena Prescribed drugs, Inc. (NASDAQ: ALNA), a late-phase, biopharmaceutical enterprise committed to creating and commercializing very first-in-class, oral enzyme therapeutics to handle clients with scarce and extreme metabolic and kidney disorders, currently declared that enterprise administration will take part in 3 approaching investor conferences in November:

29th Annual Credit history Suisse Digital Healthcare ConferenceDay: Tuesday, November 10Presentation Time: 1:15 p.m. ET

H.C. Wainwright & Co. 6th Once-a-year Israel Conference Day: Thursday, November 12Presentation Time: 11:00 a.m. ET

Jefferies Digital London Health care Meeting Day: Tuesday, November 17- Thursday, November 19Management will be accessible for a person-on-one conferences.

Dwell audio webcasts of the Credit score Suisse and H.C. Wainwright shows will be accessible beneath “Events and Presentations” in the Traders section of the Company’s web site at www.allenapharma.com. Replays of the webcasts will be accessible on the Allena web site for 30 times adhering to each individual presentation.

About Allena PharmaceuticalsAllena Pharmaceuticals, Inc. is a late-phase biopharmaceutical company committed to establishing and commercializing very first-in-class, oral enzyme therapeutics to take care of patients with scarce and serious metabolic and kidney disorders. Allena’s lead solution applicant, reloxaliase, is presently remaining evaluated in a pivotal Stage 3 medical plan for the treatment of enteric hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate ranges and generally connected with kidney stones, continual kidney illness and other significant kidney conditions. Allena is also acquiring ALLN-346, at the moment being evaluated in a Phase 1 medical trial, for the procedure of hyperuricemia in the setting of gout and sophisticated chronic kidney disorder.

Trader Make contact withHannah DeresiewiczStern Trader Relations, Inc.212-362-1200[email protected]

Media Get in touch withAdam DaleyBerry & Corporation Community Relations 212-253-8881[email protected]